Research Sample bioBank

Can’t find what you’re looking for? Contact us.

Or, need help ordering? 805.528.4341

Filter Samples By:

Get Weekly Research Sample Updates in your Inbox:

Hepatitis C (HCV) Genotype 4 Clinical Research Samples

Discovery Life Sciences provides the highest quality Hepatitis C (HCV) Genotype 4 Clinical Research Samples and Residual Diagnostic Specimens from the Life Science Industry’s only convenient online, open access Biobank. 

  • All Hepatitis C (HCV) Genotype 4 Sample Orders are Packaged for Delivery within 24 Hours. 
  • All Specimens Ethically Obtained, De-Identified and provided with Highly Annotated Demographic and Clinical Data.
  • Select from an HHS/OHRP Compliant Biorepository following ISBER/BBRB Guidelines.
  • Packaged in Compliance with all UN Regulations (6.2) and U.S. DOT Hazmat regulations. 
Showing 12 of 12 total samples
 (0)
Checkout
Advanced Data View:
Showing 12 of 12 total samples
Buy
Product IDSampleOriginMatrixVial (ml)QuantityPriceAgeGenderEthnicityStorage TempSample DateTest 1Test Data 1Sample Detail 1Test 2Test Data 2Sample Detail 2Test 3Test Data 3Product
Details
Price
Buy
Additional Information 1Additional Data 1Additional Information 2Additional Data 2Additional Information 3Additional Data 3Additional Information 4Additional Data 4Additional Detail 4Additional Information 5Additional Data 5Additional Detail 5Additional Information 6Additional Data 6Additional Information 7Additional Data 7
DLS14-24760-02Hepatitis C (HCV) Genotype 4South AfricaSerum1.007.00$200.0063 YMWhite<-70C09-Mar-16Roche COBAS AmpliPrep168,000 IU/mL9-Mar-16Versant HCV Genotype 49-Mar-16$200.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryTransfusionSymptomsFatigueAdditional TestingALT: 200 U/L; AST: 129 U/L; ALP: 83; LDH: 245; Bilirubin: 17 umol/L ; Serum Creatinine: 113 umol/L 9-Mar-2016 Hepatitis Serology ResultNoneCo-InfectionsChronic HCV
DLS17-038196Hepatitis C (HCV) Genotype 4FranceCitrated Plasma1.0010.00$95.00 U/AU/A<-70C17-Feb-12Roche cobas218,160 IU/mLLipa 24a/4c/4dSequencing (Region NS5b)4a$95.00Prism5.130 | 4.760 | 5.110Elisa4.927 | 4.906 | 4.914InnoliaC1 (4+), C2 (4+), E (1+), NS3 (4+), NS4 (3+), NS5 (1+)DGV UltrioPositive
DLS17-038207Hepatitis C (HCV) Genotype 4FranceCitrated Plasma1.0010.00$95.00 U/AU/A<-70C02-Apr-11Roche cobas5,455 IU/mLLipa 24a/4c/4dSequencing (Region NS5b)4d$95.00Prism5.020 | 4.970 | 5.210Elisa4.960InnoliaC1 (3+); C2(4+); E2 (2+); NS3 (4+); NS4 (4+); NS5 (--)PosDGVPos
DLS17-038210Hepatitis C (HCV) Genotype 4FranceCitrated Plasma1.0010.00$95.00 U/AU/A<-70C24-Jun-12Roche cobas151,774 IU/mLLipa 24Sequencing (Region NS5b)4a$95.00Prism9.370 | 9.450 | 9.430Elisa4.933DGV UltrioPosInnoliaC1 (4+); C2 (4+); E2 (4+); NS3 (4+); NS4 (4+);NS5 (2+)Pos
DLS17-038219Hepatitis C (HCV) Genotype 4FranceCitrated Plasma1.005.00$95.00 U/AU/A<-70C16-Jun-11Roche cobas761,939 IU/mLLipa 24a/4c/4dSequencing (Region NS5b)4a$95.00Prism4.942 | 4.949 | 4.949Axsym75.550InnoliaPosDGVPosAdditional ResultsHBc Positive
DLS0025528Hepatitis C (HCV) Genotype 4South AfricaSerum1.008.00$200.0063 YMWhite<-70C09-Mar-16Roche cobas168,000 IU/mLViral LoadSiemens Versant Lipa4Genotype$200.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryTransfusionSymptomsFatigueAdditional TestingALT: 200; AST: 129; ALP: 83; LDH: 245; Bilirubin: 17 umol/L; Serum Creatinine: 113 umol/L9-Mar-16Hepatitis SerologyU/ACo-InfectionsChronic HCV
DLS0025529Hepatitis C (HCV) Genotype 4South AfricaSerum1.007.00$200.0067 YMWhite<-70C02-Mar-16Roche cobas1,260,000 IU/mLViral LoadSiemens Versant Lipa4Genotype$200.003-series HepB VaccineyesIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryTransfusionSymptomsItching; FatigueAdditional TestingALT: 71; AST: 44; ALP: 116; Bilirubin: 5 umol/L; Serum Creatinine: 84 umol/L2-Mar-16Hepatitis SerologyNoneCo-InfectionsHepatitis C
DLS0025532Hepatitis C (HCV) Genotype 4South AfricaSerum1.006.00$200.0066 YMAsian<-70C01-Sep-15Roche cobas161,000 IU/mLViral LoadSiemens Versant Lipa4vGenotype$200.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryTransfusionSymptomsFatigue; Previous variceal bleedAdditional TestingALT: 101; AST: 175; ALP: 110; Bilirubin: 20 umol/L25-Aug-15Hepatitis SerologyU/ACo-InfectionsChronic HCV with Cirrhosis
DLS0057160Hepatitis C (HCV) Genotype 4South AfricaSerum1.005.00$200.0041 YMBlack<-70C11-Apr-17Roche cobas192,000 IU/mLViral LoadSiemens Versant Lipa4kGenotype$200.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryTransfusionSymptomsFatigueAdditional TestingALT: 22 U/L | AST: 43 U/L | ALP: 70 U/L | Bilirubin: 12 umol/L | Serum Creatinine:93 umol/L | Fibroscan F0 11-Apr-17Co-InfectionsHepatitis CHCV Date of Diagnosis19-Jan-2016
DLS0057161Hepatitis C (HCV) Genotype 4South AfricaSerum1.008.00$200.0049 YFBlack<-70C25-Apr-17Roche cobas347,569 IU/mLViral LoadSiemens Versant Lipa4Genotype$200.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryU/ASymptomsNo symptomsAdditional TestingALT: 35 U/L | AST: 27 U/L | ALP: 87 U/L | Bilirubin: 5 umol/L | Serum Creatinine:63 umol/L | Fibroscan F1 25-Apr-17Co-InfectionsHepatitis CHCV Date of Diagnosis25-Apr-2017
DLS0057163Hepatitis C (HCV) Genotype 4South AfricaSerum1.004.00$200.0018 YFBlack<-70C30-Jan-18Roche cobas237,783 IU/mLViral LoadSiemens Versant Lipa4Genotype$200.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryMedicalSymptomsNo symptomsAdditional TestingALT: 23 U/L | AST: 33 U/L | ALP: 88 U/L | Bilirubin: 6 umol/L | Serum Creatinine: 51 umol/L | Fibroscan F2 30-Jan-18Co-InfectionsHepatitis CHCV Date of Diagnosis3-Jan-2018
DLS16-24623Hepatitis C (HCV) Genotype 4South AfricaSerum1.009.00$200.0045 YMBlack<-70C12-Sep-17Roche111,549 IU/mLViral LoadSiemens Versant Lipa4bGenotype$200.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentYesAcquired Infection CategoryIV Drug AbuseSymptomsItching; Nausea; FatigueAdditional TestingALT: 54 U/L | AST: 99 U/L | ALP: 144 | Bilirubin: 10 umol/L | Serum Creatinine: 78 umol/L | Fibroscan F4 | 12-Sep-17Co-InfectionsHep C and Hep B, Hepatitis B HCV Date of Diagnosis16-Aug-2016

Keep in mind that all the samples comprised in the Research Sample Biobank represent only a small number of the clinical research specimens available through our Discovery Partners™ clinical research programs. If you can’t find the specific sample type, specimen or biofluids you are looking for please make sure to call our client services group at 805.528.4341 - and ask how we can help support your project from resources available at active clinical sites.

Please read carefully before purchasing:

Clinical specimens for research use only.

Transmissible Infectious Risk! May be HIV, HBV and HCV REACTIVE or of unknown infectious agent test status. Materials provided are derived from human blood, tissue and other bio-fluids. Handle all samples as if capable of transmitting infectious agents. Practice good laboratory technique and dispose of in properly marked medical waste.

If you need help searching for a LARGER SAMPLE SET with specific data elements, please contact our Client Services group who can format Excel spreadsheets for a comprehensive review of all available samples: USA (805) 528-4341

These products are supplied without warranty for suitability for specific applications or analytical determinations.

Specimens and data will be may be used for general biomarker research, assay and instrument validation purposes only. All Research products identified as “Diagnostic Remnant Samples” are human biological materials leftover from routine laboratory analysis and are de-identified (coded) to protect subject confidentiality. Under OHRP definition 45 CFR 46.102(f) these coded specimens are not considered subjects for Human research requiring informed consent. Specimens cannot be used for whole genomic sequencing of genetic material. Research products designated as “Clinical Research Samples” by “type” are obtained from IRB approved research study protocols with informed consent obtained from each subject enrolled. Specimens cannot be used for whole genomic sequencing of genetic material.